pulseData builds a suite of artificial intelligence solutions that predict the progression of chronic kidney disease and cardiorenal comorbidities. Its customers include Medicare Advantage plans, commercial health plans, self-insured employers, risk-bearing health systems, Accountable Care Organizations, and providers participating in value-based care. Led by co-founders Teddy Cha (CEO) and Hai Po Sun (CTO), the New York City-based company focuses on applying predictive algorithms to chronic disease management. In April 2021 pulseData raised $16.5m in a Series A funding round led by Bain Capital Private Equity and Two Bear Capital, with participation from Alumni Ventures Group and existing investors. The company said it will use the funds to expand operations and broaden its business reach.

Total raised

$17M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2021